The use of urinary nuclear matrix protein 22 (NMP22) as a diagnostic adjunct to urine cytology for monitoring of recurrent bladder cancer—institutional experience and review

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0339|43|4|307-314

ISSN： 8755-1039

Source： DIAGNOSTIC CYTOPATHOLOGY, Vol.43, Iss.4, 2015-04, pp. : 307-314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Diagnostic Value of the Nuclear Matrix Protein 22 Test and Urine Cytology in Upper Tract Urothelial Tumors

By  

Urologia Internationalis, Vol. 87, Iss. 2, 2011-08 ,pp. : 134-137

Karger

Access to resources Recommend Favorite

Comparison of Cytology and Nuclear Matrix Protein 22 for the Detection and Follow-Up of Bladder Cancer

By  

Urologia Internationalis, Vol. 66, Iss. 2, 2001-02 ,pp. : 72-77

Karger

Access to resources Recommend Favorite

BTA Quantitative Assay and NMP22 Testing Compared with Urine Cytology in the Detection of Transitional Cell Carcinoma of the Bladder

By  

Urologia Internationalis, Vol. 65, Iss. 2, 2000-10 ,pp. : 100-105

Karger

Access to resources Recommend Favorite

NMP 22, BTA stat Test and Cytology in the Diagnosis of Bladder Cancer: A Comparative Study

By  

Urologia Internationalis, Vol. 66, Iss. 4, 2001-05 ,pp. : 185-190

Karger

Access to resources Recommend Favorite

Diagnostic Value of Voided Urine and Bladder Barbotage Cytology in Detecting Transitional Cell Carcinoma of the Urinary Tract

By  

Urologia Internationalis, Vol. 62, Iss. 1, 1999-07 ,pp. : 26-30

Karger

Access to resources Recommend Favorite